These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32042417)

  • 1. Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Takahashi Y; Honda T; Yajima H; Uehara R; Hino N; Hirata R; Taura N; Nakao K
    Biomed Rep; 2020 Mar; 12(3):89-98. PubMed ID: 32042417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated body muscle mass as a useful screening marker for low skeletal muscle mass and sarcopenia in chronic liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Honda T; Yajima H; Uehara R; Miyazaki O; Hino N; Hirata R; Taura N; Nakao K
    Hepatol Res; 2020 Jun; 50(6):704-714. PubMed ID: 32061107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease.
    Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Uehara R; Miyazaki O; Kuribayashi Y; Kira K; Taura N; Nakao K
    Biomed Rep; 2021 Apr; 14(4):34. PubMed ID: 33732453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
    Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
    Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
    Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
    Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
    Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
    Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
    Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
    BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between oral frailty and cystatin C-related indices-A questionnaire (OFI-8) study in general internal medicine practice.
    Kusunoki H; Ekawa K; Kato N; Yamasaki K; Motone M; Shinmura K; Yoshihara F; Shimizu H
    PLoS One; 2023; 18(4):e0283803. PubMed ID: 37093792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
    Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
    Front Nutr; 2022; 9():963265. PubMed ID: 36118766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes.
    Shin JY
    Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1454-1462. PubMed ID: 35256230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
    Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of glomerular filtration rate based on dry lean body mass in kidney transplant recipients
.
    Borštnar Š; Lindič J; Ležaič L; Sočan A; Godnov U; Kovač D
    Clin Nephrol; 2019 Dec; 92(6):287-292. PubMed ID: 31587755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis.
    Omar M; Abdel-Razek W; Abo-Raia G; Assem M; El-Azab G
    Int J Hepatol; 2015; 2015():309042. PubMed ID: 26550493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak correlation between total psoas muscle area and sarcopenia index for children with brain tumor.
    Wang Z; Zeng S; Liu L; Zhong X; Cai L
    Nutr Clin Pract; 2023 Aug; 38(4):838-849. PubMed ID: 37087682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
    Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
    Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries.
    Erlandsen EJ; Hansen RM; Randers E; Petersen LE; Abrahamsen J; Johannesen IL
    Spinal Cord; 2012 Oct; 50(10):778-83. PubMed ID: 22547045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease.
    An JN; Kim JK; Lee HS; Kim SG; Kim HJ; Song YR
    Kidney Res Clin Pract; 2022 Sep; 41(5):580-590. PubMed ID: 35791742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
    Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis.
    Krones E; Fickert P; Zitta S; Neunherz S; Artinger K; Reibnegger G; Durchschein F; Wagner D; Stojakovic T; Stadlbauer V; Fauler G; Stauber R; Zollner G; Kniepeiss D; Rosenkranz AR
    BMC Nephrol; 2015 Dec; 16():196. PubMed ID: 26627205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of creatinine cystatin C ratio with muscle mass and grip strength in memory clinic outpatients.
    Yamada Y; Umegaki H; Sugimoto T; Nagae M; Komiya H; Watanabe K; Sakurai T
    Exp Gerontol; 2022 Oct; 168():111935. PubMed ID: 36038035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.